| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090849 Protein kinase inhibitors, in particular inhibitory properties for CIV1 protein; N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride; fungal diseases such as candidiases, aspergilloses, histoplasmoses and coccidoidoses; fungicidal infections |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090840 Heterocyclic GPR40 Modulators |
| 04/17/2008 | US20080090837 Biaryls useful as modulators of ion channels |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090791 3 beta -hydroxy-16 alpha -fluoro-17 beta -aminoandrost-5-ene; immunostimulant, antiinflammatory agent; neutropenia, infections, blood cell deficiencies; interleukin, tumor necrosis factor, macrophage inflammatory protein, transforming growth factor, cyclooxygenase, and lipoxygenase inhibitor |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090786 Atherosclerosis; ethyl (E)-2-(4-hydroxy-3-methoxyphenyl)vinyl-phosphonofluoridoate; fluorination of organophosphorus compounds, including organothiophosphorus compounds, to form corresponding fluoro(thio)phosphorus compounds |
| 04/17/2008 | US20080090783 LPA Receptor Agonists and Antagonists and Methods of Use |
| 04/17/2008 | US20080090777 Long lasting drug formulations |
| 04/17/2008 | US20080090775 Antagonist of TEB4 and Methods of Use |
| 04/17/2008 | US20080090765 Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage |
| 04/17/2008 | US20080090761 Method Comprising Nanofiltration to Obtain an Mbl Product Safe from Infectious Agents and the Product Obtainable by This Method |
| 04/17/2008 | US20080090759 Methods and kits for predicting risk for preterm labor |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090754 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; zinc; stabilized against denaturing when in contact with an organic solvent |
| 04/17/2008 | US20080090750 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis, antiproliferative, and in the diagnosis of diseases of human pregnancy involving abnormal placenta, preeclampsia and intrauterine growth retardation |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080090000 From olives; incubating the acidified water until at least 75 percent of oleoeuropein has been converted to hydroxytyrosol; nutraceuticals in tablet, capsule, pill or confection form; antioxidants |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089961 Consists of 2 to 95 weight percent Eleuthero; 2 to 95 weight percent Stephania; and, 2 to 95 weight percent Epimedium; for treating flu and cold; kits |
| 04/17/2008 | US20080089954 Diagnosis and treatment of human dormancy syndrome |
| 04/17/2008 | US20080089952 Compositions and methods for coating medical implants |
| 04/17/2008 | US20080089939 Dermastick thickened ointment |
| 04/17/2008 | US20080089928 Liposome drug carriers with ph-sensitivity |
| 04/17/2008 | US20080089925 Drug for External Use and Adhesive Patch |
| 04/17/2008 | US20080089910 Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089905 Blueberry, carnosine, catechin, green tea extract, VitaBlue, Vitamin D3; for self-repair of injury in mammals; cell proliferation, cell differentiation; ethanol extract of Aphanizomenon flos-aqaue omega (a blue-green algae); dietary supplement known as Spirulina |
| 04/17/2008 | US20080089903 Cd4+t-lymphocyte-specific hepatitis c virus epitopes |
| 04/17/2008 | US20080089899 Streptococcus pneumoniae proteins and nucleic |
| 04/17/2008 | US20080089892 Fc Region Variants |
| 04/17/2008 | US20080089891 Cancerous disease modifying antibodies |
| 04/17/2008 | US20080089889 Novel Bone Metastasis Marker Peptide and Method of Diagnosing Bone Metastasis by Using the Same |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089875 Methods and compositions for the treatment of cancer |
| 04/17/2008 | US20080089872 Method for purifying pluri-differentiated mesenchymal progenitor cells |
| 04/17/2008 | US20080089865 Nutrient broth comprising no cell attachment factors for use in propagation of neuronal cell lines |
| 04/17/2008 | US20080089862 Serine protease inhibitor for prevention and treatment of cell proliferative, liver and inflammatory disorders |
| 04/17/2008 | US20080089841 Continuous Vessel-Selective Spin Labeling |
| 04/17/2008 | CA2666373A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | CA2664054A1 An antidepressant comprising a branched amino acid |
| 04/16/2008 | EP1911789A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911788A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911760A1 Xanthine oxidase inhibitor |
| 04/16/2008 | EP1911757A2 Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911471A1 Agent for visualizing vitreous body |
| 04/16/2008 | EP1911449A1 Anti-tumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 04/16/2008 | EP1911448A2 Lipoxins and Aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1911445A2 Stable pharmaceutical formulation comprising an HMG-COA reductase inhibitor |
| 04/16/2008 | EP1910844A2 Cross-beta structure binding compounds |
| 04/16/2008 | EP1910526A2 Methods for the administration of fv and related compositions |
| 04/16/2008 | EP1909846A2 Triazole-containing releasable linkers, conjugates thereof, and methods of preparation |
| 04/16/2008 | EP1909821A2 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1349559B1 Compositions for inducing secretion of insulin-like growth factor-1 |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP1075491B1 Pth2 receptor selective compounds |
| 04/16/2008 | CN101163684A Quinazoline derivative having tyrosine kinase inhibitory activity |
| 04/16/2008 | CN101161677A Recombinant polypeptide having islets beta- cell protection function |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161282A Blood circulation promoting nourishing kidney health preserving electric girdle |
| 04/16/2008 | CN101161264A A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction |
| 04/16/2008 | CN101161246A New purpose of ginsenoside Rh* |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381446C Aminomethyl-substituted thiazolobenzimidazole derivative |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381176C Method for introducing nucleic acids and other biologially active molecules into nucleus of higher exkaryotic cells by means of electrical current |
| 04/16/2008 | CN100381138C Chinese medicinal preparation for treating finger tip injury |
| 04/16/2008 | CN100381061C Method for preparing digestion-promoting spleen-invigorating yoghourt with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358415 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358342 Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |